In the drug development process, preclinical studies serve as a critical phase where potential therapeutic candidates undergo rigorous evaluation before entering clinical trials. At the heart of these studies lies bioanalysis, a vital tool that determines the pharmacokinetic (PK) and pharmacodynamic (PD) properties of drug candidates. This article explores the role of bioanalysis in preclinical studies, highlighting its significance, methodologies, and the comprehensive services offered by InfinixBio.
Bioanalysis involves the quantitative measurement of drugs, metabolites, and biomarkers in biological samples. Its primary goal is to generate reliable data that informs the safety and efficacy of drug candidates. In the context of preclinical studies, bioanalysis provides essential insights that guide decision-making processes, ensuring only the most promising candidates transition into human trials.
Drug Absorption, Distribution, Metabolism, and Excretion (ADME) Evaluation
Pharmacokinetic and Pharmacodynamic Studies
Immunogenicity Assessment
Dose Escalation Studies
LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry)
Sample Handling and Preparation
Compliance with regulatory standards, such as GLP (Good Laboratory Practice), is imperative for bioanalytical laboratories. InfinixBio adheres to stringent quality standards in its bioanalytical services to ensure the integrity and reliability of data collected throughout preclinical studies. Learn more about our commitment to preclinical CRO quality standards.
Bioanalysis provides critical information on drug PK and PD, informing the safety and efficacy of drug candidates during the preclinical phase.
Bioanalysis informs decisions related to dosing, safety assessments, and candidate selection, guiding the transition from preclinical studies to clinical trials.
Common techniques include LC-MS/MS, immunoassays, and other advanced methods designed for sensitivity and specificity in measuring drug levels.
The role of bioanalysis in preclinical studies is indispensable. It equips researchers and drug developers with the insights they need to move forward confidently, ensuring the integrity and progression of promising therapeutic candidates. By leveraging advanced bioanalytical techniques and adhering to stringent regulatory standards, InfinixBio stands ready to support biotech and pharmaceutical companies throughout the drug development lifecycle.
For tailored solutions that meet your specific preclinical research needs, contact us today.
Our experienced lab team is here to help. Reach out today to learn more.